1. Home
  2. ROCK vs MYGN Comparison

ROCK vs MYGN Comparison

Compare ROCK & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

HOLD

Current Price

$41.27

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.66

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROCK
MYGN
Founded
1972
1991
Country
United States
United States
Employees
2221
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
481.6M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
ROCK
MYGN
Price
$41.27
$4.66
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$7.64
AVG Volume (30 Days)
268.1K
1.5M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,135,501,000.00
$771,400,000.00
Revenue This Year
$24.00
$7.19
Revenue Next Year
$34.38
$5.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$37.80
$3.76
52 Week High
$75.08
$10.32

Technical Indicators

Market Signals
Indicator
ROCK
MYGN
Relative Strength Index (RSI) 32.26 41.35
Support Level N/A $3.93
Resistance Level $51.86 $5.63
Average True Range (ATR) 2.11 0.42
MACD -0.40 0.04
Stochastic Oscillator 25.95 21.43

Price Performance

Historical Comparison
ROCK
MYGN

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: